Javascript must be enabled to continue!
Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India
View through CrossRef
Summary. The objective of this study was to assess the frequency of factor VIII (FVIII) gene intron 1 and intron 22 inversions and the informativeness of polymorphic markers for the genetic diagnosis of patients with haemophilia A (HA). Fifty unrelated patients with HA were first assessed for the intron 1 and intron 22 inversion mutations. Inversion‐negative families were then screened for the bi‐allelic intragenic markers – intron 7 G→A polymorphism, HindIII site in intron 19 and XbaI site in intron 22 and the multiallelic dinucleotide CA repeat alleles in introns 13 and 22. The extragenic, multiallelic VNTR DXS52 (st14) was also analysed. Intron 22 inversion mutation was found in 38% (n = 19) of all patients and 46% of those with severe HA. Intron 1 inversion was found in one (2%) patient. Of the 30 inversion‐negative families, XbaI site polymorphism was the single most informative marker (70%, n = 21/30) followed by HindIII (60%, n = 18/30), intron 13 CA repeats (56.66%, n = 17/30), intron 22 CA repeats (50%, n = 15/30), DXS52 VNTR (23.33%, n = 7/30) and intron 7 G→A polymorphism (6.66%, n = 2/30). The combined use of these markers was informative in 92% (n = 46/50) of HA families. Based on the informativeness of these markers a comprehensive algorithm has been proposed for genetic diagnosis of HA in India.
Title: Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India
Description:
Summary.
The objective of this study was to assess the frequency of factor VIII (FVIII) gene intron 1 and intron 22 inversions and the informativeness of polymorphic markers for the genetic diagnosis of patients with haemophilia A (HA).
Fifty unrelated patients with HA were first assessed for the intron 1 and intron 22 inversion mutations.
Inversion‐negative families were then screened for the bi‐allelic intragenic markers – intron 7 G→A polymorphism, HindIII site in intron 19 and XbaI site in intron 22 and the multiallelic dinucleotide CA repeat alleles in introns 13 and 22.
The extragenic, multiallelic VNTR DXS52 (st14) was also analysed.
Intron 22 inversion mutation was found in 38% (n = 19) of all patients and 46% of those with severe HA.
Intron 1 inversion was found in one (2%) patient.
Of the 30 inversion‐negative families, XbaI site polymorphism was the single most informative marker (70%, n = 21/30) followed by HindIII (60%, n = 18/30), intron 13 CA repeats (56.
66%, n = 17/30), intron 22 CA repeats (50%, n = 15/30), DXS52 VNTR (23.
33%, n = 7/30) and intron 7 G→A polymorphism (6.
66%, n = 2/30).
The combined use of these markers was informative in 92% (n = 46/50) of HA families.
Based on the informativeness of these markers a comprehensive algorithm has been proposed for genetic diagnosis of HA in India.
Related Results
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
AbstractIntroductionEmergence of new therapies are anticipated to improve clinical outcomes and quality of life of persons with haemophilia. Challenges in conducting randomized cli...
Haemophilia treatment in 2030
Haemophilia treatment in 2030
IntroductionLooking into the future is difficult and sometimes hazardous. A reliable look into haemophilia treatment in 2030 should be based on history and contemporary progress as...
Normalisation of Haemostasis in Haemophilia A
Normalisation of Haemostasis in Haemophilia A
Haemophilia A (Factor VIII [FVIII] levels ≤40 IU/dL) is a chronic condition with consequences beyond bleeding complications. Many people with haemophilia A (PwHA) experience pain, ...
Preventing bleeds by treatment: new era for haemophilia changing the paradigm
Preventing bleeds by treatment: new era for haemophilia changing the paradigm
IntroductionCoagulation products have allowed patients with severe haemophilia to lead a normal life. This is, however, only true for patients who received an early diagnosis and c...
Bioclinical features of haemophilia patients in Benin in 2023: Towards better care
Bioclinical features of haemophilia patients in Benin in 2023: Towards better care
AbstractObjectiveTo analyse the demographic, clinical and laboratory data of Beninese patients with haemophilia.MethodA prospective survey was conducted in three different hospital...
Sexual expression, fulfilment and haemophilia: reflections from the 16th Australian and New Zealand Haemophilia Conference
Sexual expression, fulfilment and haemophilia: reflections from the 16th Australian and New Zealand Haemophilia Conference
Summary. Following a presentation given at the 16th Australian and New Zealand Haemophilia Conference; Enjoying your sex life: Issues and solutions for men with physical impairmen...
Hemgenix as First Gene Therapy for Treatment of Haemophilia B
Hemgenix as First Gene Therapy for Treatment of Haemophilia B
We know about haemophilia B is an inheritable bleeding complaint performing from missing or inadequate situations of blood clotting Factor IX, a protein demanded to produce blood c...
Why Do Indians Experience Less Happiness Than Pakistanis?
Why Do Indians Experience Less Happiness Than Pakistanis?
This study explores the enigma of happiness inequality between India and Pakistan, despite India’s economic prowess. Employing inequality regression models, the study pinpoints cru...

